Brief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
BRIEF-Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results Humacyte Inc HUMA.O:
HUMACYTE ANNOUNCES LANCET DIGITAL HEALTH PUBLICATION OF V007 PHASE 3 HEMODIALYSIS ACCESS TRIAL RESULTS
Source text: ID:nGNX99RjKr
Further company coverage: HUMA.O
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary